Grainger, John D. http://orcid.org/0000-0003-2626-0647
Kühne, Thomas
Hippenmeyer, Jane http://orcid.org/0000-0002-5480-8916
Cooper, Nichola
Funding for this research was provided by:
Amgen
Article History
Received: 22 March 2021
Accepted: 28 June 2021
First Online: 26 July 2021
Declarations
:
: Not applicable.
: Not applicable.
: Not applicable.
: J.D. Grainger has participated in advisory boards for Alexion, Amgen, Biotest, Dova, and Novartis.T. Kühne has received research funds from Amgen and Novartis and has participated in advisory boards for Amgen, Novartis, UCB, and SOBI.J. Hippenmeyer is an employee of Amgen and owns shares in Amgen.N. Cooper has received fees for speaking at educational meetings and for consultancy work from Amgen, Glaxo-SmithKline, and Novartis, and has received research funding in part by Imperial College BRC, the National Organization for Rare Disorders, and the UK ITP Support Association.